Skip to main content
Log in

Effects of aprotinin on hemorrhagic complications in ARDS patients during prolonged extracorporeal CO2 removal

  • Case Reports
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

The effects of aprotinin, a broad-based proteinase inhibitor, in the management of hemorrhagic complications during prolonged venovenous extracorporeal CO2 removal in patients with adult respiratory distress syndrome are not evaluated. In two patients, aprotinin infusion was added to heparin to treat bleeding, occurring after few days of bypass and responsible for respiratory and hemodynamic deterioration. After aprotinin infusion (loading dose of 2×106 kIU followed by a continuous infusion of 5×105 kIU/h) combined with heparin, bleeding vanished until the end of bypass.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Uziel L, Agostini A, Pirovano E (1982) Haematologic survey during low frequency positive pressure ventilation with extracorporeal CO2 removal. Trans Am Soc Artif Intern Organs 28:359–364

    PubMed  Google Scholar 

  2. McCoy-Pardington D, Judd WJ, Knafl P, Abruzzo LV, Coombes KR, Butch SH, Oberman HA (1990) Blood use during extracorporeal membrane oxygenation. Transfusion 30:307–309

    PubMed  Google Scholar 

  3. Green TP, Ischam-Schopf B, Steinhorn RH, Smith C, Irmiter RJ (1990) Whole blood activating clotting time in infants during extracorporeal membrane oxygenation. Crit Care Med 18:494–498

    PubMed  Google Scholar 

  4. Verstraete M (1985) Clinical application of inhibitors of fibrinolysis. Drugs 29:236–261

    PubMed  Google Scholar 

  5. Van Oeveren W, Jansen NJG, Bidstrup BP, Royston D, Westaby S, Neuhof H, Wildevuur CRH (1987) Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg 44:640–645

    PubMed  Google Scholar 

  6. Royston D, Taylor KM, Bidstrup BP, Sapsford RN (1987) Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet II:1289–1291

    Google Scholar 

  7. Dietrich W, Barankay A, Dilthey G, Henze R, Niekau E, Sebening F, Richter JA (1989) Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application. Clinical experience in 152 cardiac surgical patients. Thorac Cardiovasc Surg 37:92–98

    PubMed  Google Scholar 

  8. Fraedrich G, Weber C, Bernard C, hettwer A, Schlosser V (1989) Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinin. Preliminary results. Thorac Cardiovasc Surg 37:89–91

    PubMed  Google Scholar 

  9. Cattinoni L, Pesenti A, Mascheroni D et al. (1986) Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 256:881–886

    PubMed  Google Scholar 

  10. Moriau M, Rodhain J, Noel H, De Beys-Col C, Masure R (1974) Comparative effects of proteinase inhibitors plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental DIC induced by thrombin. Thromb Haemostat 32:171–188

    Google Scholar 

  11. Hugues B, Parratt JR (1985) The effects of the protease inhibitor, aprotinin, on the course of shock induced by endotoxin in cats. Br J Pharmacol 86:399–403

    PubMed  Google Scholar 

  12. Vandeplassche G, Schrauwen E, Houvenaghel (1983) Effects of the protease inhibitor aprotinin in endotoxin-shocked piglets. IRCS Med Sci 11:318–319

    Google Scholar 

  13. Winn R, Gleisner J, Maunder R, Harlan J, Hildebrant J (1986) Lung permeability and hemodynamics during endotoxemia: effect of aprotinin. J Surg Res 41:620–626

    PubMed  Google Scholar 

  14. Etienne A, Hecquet F, Guilmard C, Soulard C, Braquet P (1987) Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity. Int J Tissue Reac 9:19–26

    Google Scholar 

  15. Katsuura Y, Kimura Y, Ohno N, Naito T, Okamoto S, Wanaka K (1989) DIC with and without MOF like syndrome: effect of selective synthetic-inhibitor (abstract). Thromb Haemostat 62:372

    Google Scholar 

  16. Svartholm E, Haglund U, Ljungberg J, Hedner U (1989) Influence of aprotinin, a protease inhibitor, on porcineE. coli shock. Acta Chir Scand 155:7–13

    PubMed  Google Scholar 

  17. Chalkladakis GE, Kostakis A, Karydakis P et al. (1985) Effect of aprotinin on fibrinopurulent peritonitis in rats. Am J Surg 150:550–553

    PubMed  Google Scholar 

  18. Haberland G, McConn R (1979) A rationale for the therapeutic action of aprotinin. Fed Proc 38:2760–2767

    PubMed  Google Scholar 

  19. Putterman C (1989) Aprotinin therapy in septic shock (letter). Acta Chir Scand 155:367

    PubMed  Google Scholar 

  20. Martinez-Brotons F, Oncins JR, Mestres J, Amargos V, Reynaldo C (1987) Plasma kallicrein-kinin system in uncomplicated sepsis and septic shock-comparison with cardiogenic shock. Thromb Haemostat 58:709–713

    Google Scholar 

  21. Harker LA, Malpass TW, Branson HE, Hessel EA II, Slichter SJ (1980) Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. Blood 56:824–834

    PubMed  Google Scholar 

  22. Holloway DS, Summaria L, Sandesara J, Vagher JP, Alewander JC, Caprini JA (1988) Decreased platelet number and function and increased fibrinolysis contribute to post operative bleeding in cardiopulmonary bypass patients. Thromb Haemostat 59:62–67

    Google Scholar 

  23. Tanaka K, Takao M, Yada I, Yuasa H, Kusagawa M, Degushi K (1989) Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth 3:181–188

    PubMed  Google Scholar 

  24. Van Oeveren W, Jansen NJG, Bidstrup BP, Royston D, Westaby S, Neuhof H, Wildevuur CRH (1987) Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg 44:640–645

    PubMed  Google Scholar 

  25. Van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH (1990) Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 99:788–797

    PubMed  Google Scholar 

  26. Dietrich W, Spannagl M, Jochum M et al. (1990) Influence of highdose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology 73:1119–1126

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brunet, F., Mira, J.P., Belghith, M. et al. Effects of aprotinin on hemorrhagic complications in ARDS patients during prolonged extracorporeal CO2 removal. Intensive Care Med 18, 364–367 (1992). https://doi.org/10.1007/BF01694366

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01694366

Key words

Navigation